首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II
【24h】

Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II

机译:吡唑基磺酰胺金属配合物对人红细胞碳酸酐酶同工酶I和II的合成,表征和体外抑制

获取原文
           

摘要

Nurgün Büyükk?dan a* , Bülent Büyükk?dan a , Metin Bülbül a , Rahmi Kas?mo?ullar? a & Samet Mert a a Department of Chemistry , Arts and Science Faculty, Dumlupinar University , Kutahya , Turkey CONTACT Dr. Nurgün Büyükk?dan nurgun. buyukkidan@dpu. edu. tr Department of Chemistry , Arts and Science Faculty, Dumlupinar University , 43100 Kutahya , Turkey Supplemental data for this article can be accessed here Sulfonamides represent an important class of biologically active compounds. A sulfonamide possessing carbonic anhydrase (CA) inhibitory properties obtained from a pyrazole based sulfonamide, ethyl 1-(3-nitrophenyl)-5-phenyl-3-((5-sulfamoyl-1,3,4-thiadiazol-2-yl)carbamoyl)-1H-pyrazole-4-carboxylate ( 1 ), and its metal complexes with the Ni(II) for ( 2 ), Cu(II) for ( 3 ) and Zn(II) for ( 4 ) have been synthesized. The structures of metal complexes ( 2 – 4 ) were established on the basis of their elemental analysis, 1H NMR, IR, UV–Vis and MS spectral data. The inhibition of two human carbonic anhydrase (hCA, EC 4.2.1.1) isoenzymes I and II, with 1 and synthesized complexes ( 2 – 4 ) and acetazolamide (AAZ) as a control compound was investigated in vitro by using the hydratase and esterase assays. The complexes 2 , 3 and 4 showed inhibition constant in the range 0.1460–0.3930?μM for hCA-I and 0.0740–0.0980?μM for hCA-II, and they had effective more inhibitory activity on hCA-I and hCA-II than corresponding free ligand 1 and than AAZ.
机译:NurgünBüyükk?dan a * ,BülentBüyükk?dan a ,MetinBülbül a ,Rahmi Kas?mo? ? a 和Samet Mert a a 杜姆鲁皮纳尔大学化学,艺术和科学系,土耳其库塔赫亚联系方式NurgünBüyükk?dan nurgun博士。 buyukkidan @ dpu。 edu。 dumlupinar大学化学,艺术与科学学院,土耳其库塔希亚43100,本文的补充数据可在此处访问磺酰胺类药物是生物活性化合物的重要类别。由吡唑基磺酰胺乙基1-(3-硝基苯基)-5-苯基-3-((5-氨磺酰基-1,3,4-噻二唑-2-基)所获得的具有碳酸酐酶(CA)抑制性能的磺酰胺合成了(1)的氨基甲酰基)-1H-吡唑-4-羧酸盐(1)及其与(2)的Ni(II),(3)的Cu(II)和(4)的Zn(II)的金属配合物。根据其元素分析, 1 1H NMR,IR,UV-Vis和MS光谱数据建立了金属配合物(2-4)的结构。使用水合酶和酯酶测定法在体外研究了两种人碳酸酐酶(hCA,EC 4.2.1.1)同工酶I和II对1和合成的配合物(2-4)和乙酰唑酰胺(AAZ)的抑制作用。配合物2、3和4对hCA-I的抑制常数在0.1460-0.3930μM范围内,对hCA-II的抑制常数在0.0740-0.0980μm范围内,并且它们对hCA-I和hCA-II的抑制活性比对游离配体1比AAZ大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号